click to enlarge
Brian Strahl, PhD
Dr. Strahl is one of 38 investigators recently awarded the EUREKA grant from the National Institutes of Health (NIH). A total of $42.2 million in grants were awarded in this new program.
EUREKA (an acronym for Exceptional, Unconventional Research Enabling Knowledge Acceleration) is a program that targets scientists who are experimenting on novel hypotheses. The potential impact of the proposed research must be substantial in terms of both the size of the scientific community affected and the magnitude of its impact on the community. According to NIH Director, Dr. Elias A. Zerhouni “The program reflects NIH’s commitment to supporting potentially transformative research, even if it carries a greater than usual degree of scientific risk.”
Almost 8 years ago, Drs. David Allis and Brian Strahl formally proposed the ‘histone code’ hypothesis to explain how distinct histone modifications could regulate epigenetic inheritance, gene expression and the control of cell growth. However, limited experimental support exists for this hypothesis, and to date, it is unclear whether the binding of DNA-associated proteins to combinatorially modified histones is a universal phenomenon of these regulators or is restricted to a subset of histone-binding proteins. With funds from his EUREKA award, Dr. Strahl’s group proposes to develop new approaches and technologies to crack the underlying basis of the ‘histone code’.
Dr. Strahl’s previous accomplishments include being chosen as a Pew Scholar, receiving the UNC Jefferson Pilot Award, Presidential Early Career Award, and the ASBMB Schering-Plough Award.
For a complete list of all EUREKA grant awardees: http://www.nigms.nih.gov/Research/Mechanisms/EUREKAGrants.htm
Related UNC news release: UNC scientist receives new NIH grant for 'exceptional' research
- Faculty News
ASBMB Today highlights Henrik Dohlman as a new JBC associate editor
Learn more about Henrik Dohlman, professor and vice chair of biochemistry and biophysics, from his profile highlight in ASBMB Today's December 2013 issue.
Sharon Campbell organizes the ASBMB Special Symposia Series to be held July 2014
Learn more about the event "Translating the Biophysics of Molecular Switches: Signaling Mechanisms and Inhibition of Ras and Rho GTPases"
New findings from the Carter lab challenge assumptions about origins of life
Dr. Charles Carter, Jr., Professor of Biochemistry and Biophysics resurrect “molecular fossils” to conduct experiments that undercut the predominant scientific theory of how life began on Earth.
Congratulations to Greg Wang, Assistant Professor of Biochemistry and Biophysics, who was awarded a Jefferson Pilot Fellowship from UNC School of Medicine to further his research mission searching for better ways to shut down cancer cells.
- Postdoc & Scholars News
2013 Retreat Winners
Scott Rothbart receives a 2013 UNC Pagano Award for a best first-author postdoctoral paper
Congratulations to Dr. Scott Rothbart, a postdoctoral fellow in Dr. Brian Strahl's lab who is one of the recipients this year of a Joseph S. Pagano award
Shobhan Gaddameedhi receives CEHS-2013 Pilot Project Award
Congratulations to Dr. Shobhan Gaddameedhi, postdoctoral fellow in Dr. Aziz Sancar's lab, received $25,000 from the Center for Environmental Health and Susceptibility 2013 Pilot Project Award.
Rothbart receives a 2013 Postdoctoral Award for Research Excellence
Congratulations to Dr. Rothbart, postdoctoral fellow in the lab of Dr. Brian Strahl, Associate Professor of Biochemistry and Biophysics, who received a 2013 Postdoctoral Award for Excellence in Research at UNC.